Blood Pressure and Cholesterol Treatment Study
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a combination of two new medications (QCZ484 and inclisiran) designed to lower both blood pressure and cholesterol levels. You may be a good fit if you have high blood pressure and high cholesterol that isn't fully controlled by current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 75 years old
- Diagnosed with high blood pressure (systolic reading between 140–165 mmHg)
- Taking 0, 1, or 2 blood pressure medications at a stable dose for at least 4 weeks
- Diagnosed with high cholesterol not fully controlled by statin medication
- Fasting LDL cholesterol ('bad' cholesterol) between 70–190 mg/dL and triglycerides below 400 mg/dL
- No symptoms of dizziness when standing up from lying down
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
This study tests two newer cholesterol-lowering medications (inclisiran and alirocumab) together in people who've had heart problems or strokes and cannot tolerate standard cholesterol drugs. The goal is to see if this combination safely lowers cholesterol further and reduces future cardiovascular events.
This trial tests a new version of inclisiran, a cholesterol-lowering medicine, to see if it is safe and works well. The study compares it to the current version. You may qualify if you have moderately high cholesterol but have never taken cholesterol medications.
Hear when a new Hypercholesterolaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.